Emetine Hydrochloride and Dehydroemetine Combined with Chloroquine in the Treatment of Children with Amoebic Liver Abscess

Total Page:16

File Type:pdf, Size:1020Kb

Emetine Hydrochloride and Dehydroemetine Combined with Chloroquine in the Treatment of Children with Amoebic Liver Abscess Arch Dis Child: first published as 10.1136/adc.43.227.121 on 1 February 1968. Downloaded from Arch. Dis. Childh., 1968, 43, 121. Emetine Hydrochloride and Dehydroemetine Combined with Chloroquine in the Treatment of Children with Amoebic Liver Abscess J. N. SCRAGG and S. J. POWELL* From the Departments of Paediatrics and Child Health, and Medicine, University of Natal, and the Amoebiasis Research Unitt, Durban, South Africa A combination of emetine hydrochloride with amoebic liver abscess was confirmed by the aspiration chloroquine yields better results than either drug of characteristic pus from the liver in all patients: in 17 alone in the treatment of amoebic liver abscess in of the 24 aspirates trophozoites of Entamoeba histolytica adults (Wilmot, Powell, and Adams, 1959). A were identified. In all except one patient, a 7-week-old infant, the amoebic gel-diffusion test was positive. similar combination of dehydroemetine with chloro- All patients received chloroquine, 15 mg. base/kg. day, quine is equally satisfactory (Wilmot, Powell, orally for 21 days, and in addition were randomly placed MacLeod, and Elsdon-Dew, 1964; Powell, Wilmot, on either emetine hydrochloride, 1 mg./kg. day, or MacLeod, and Elsdon-Dew, 1967). Dehydro- dehydroemetine, 2 mg./kg. day, by subcutaneous emetine is claimed to be less cardiotoxic than injection for 10 days. Those with active dysentery also emetine (Schwartz and Herrero, 1965), and in received oral tetracycline to combat intestinal amoebiasis. adults it produces fewer electrocardiographic In 22 patients repeated aspirations of the liver were copyright. changes when given in identical dosage (Powell, required, and in 6 surgical drainage of the abscess was 1967) so that up to 2 mg./kg. day have been given eventually necessary, but no additional amoebicides were with apparent safety (Powell, Wilmot, MacLeod, given. and Elsdon-Dew, 1965). In children, amoebic liver abscess carries a high Results mortality (Scragg, 1960), but a comparative trial of The results are summarized in the Table. emetine hydrochloride and chloroquine did not Necropsy findings. It will be noted that 3 show that cardiac toxicity from emetine was a factor patients who received emetine combined with http://adc.bmj.com/ in causing death (Scragg and Powell, 1966). The chloroquine died. One, a malnourished 16-month- results suggested that emetine was well tolerated old infant with active dysentery, died 48 hours by children and that, as in adults, emetine combined after beginning treatment; necropsy showed mul- with chloroquine might provide the most effective tiple abscesses which had destroyed most of the treatment. right lobe of the liver. A second patient, aged 14 The present trial reports the results of combining months, was critically ill with kwashiorkor and either emetine hydrochloride or dehydroemetine bronchopneumonia and died following surgical on September 28, 2021 by guest. Protected with chloroquine in children with amoebic liver drainage on the 24th day; a chronic non-liquefied abscess. abscess in the left lobe of the liver was found at Material and Methods TABLE Studies were made on 24 African children, their ages ranging from 1 month to 11 years. The diagnosis of Results of Treatment Received June 9, 1967. No. of No. of No. of No. of Patients Cures Deaths Relapses * Requests for reprints should be addressed to S. J. Powell, Amoebiasis Research Unit, P.O. Box 1035, Durban, South Africa. Emetine hydro- chloride. 12 9 3O t The Amoebiasis Research Unit is sponsored by the following Dehydroemetine 12 1 1 1 O bodies: The South African Council for Scientific and Industrial ..I Research; The Natal Provincial Administration; The University of Natal; and the United States Public Health Service (Grant AI 01592). Both drugs were given in combination with chloroquine. 121 Arch Dis Child: first published as 10.1136/adc.43.227.121 on 1 February 1968. Downloaded from 122 Scragg and Powell necropsy. The third infant, 1 month old, died on intervention is undesirable, but in selected instances the 9th day; necropsy was refused. open drainage has a more important place in the One patient who received dehydroemetine and management of children than of adults. chloroquine died on the 5th day. This was an In view of such clinical variations, comparison of extremely ill 13-month-old infant with profound the efficacy of drugs must be interpreted with anaemia and jaundice; at necropsy multiple abscesses caution. Nevertheless, it appears that either in the liver were present, one occupying the whole emetine or dehydroemetine can be combined with of the right lobe. chloroquine with safety and advantage. Although the immediate case fatality rate may not be signifi- Electrocardiographic findings. Electrocar- cantly influenced by combined therapy, the absence diograms were obtained before and after completion of relapse in our present trial contrasts with our of treatment in 8 of the group who received emetine previous experience using single drugs. and in 11 of those given dehydroemetine. No For the treatment of adults dehydroemetine is arrhythmias, conduction defects, or significant marginally preferred to emetine (Powell et al., 1965). tachycardia were observed. However, T wave Only long usage will tell if it is more effective in inversion developed in 6 children given emetine children though we believe that it is. Because it and in 3 who received dehydroemetine. may be slightly more effective and can be given in larger dosage, dehydroemetine is the drug of Follow-up. Ten children attended for follow- choice and should be given with chloroquine for up from 1 to 8 months after discharge. None the treatment of amoebic liver abscess in children. had relapsed. Summary Discussion Emetine hydrochloride combined with chloro- The results of therapy are difficult to assess in quine cured 9 of 12 children with amoebic liver children with amoebic liver abscess for several abscess. An alternative combination of dehydro- reasons. Even in areas where the disease is emetine with chloroquine produced cure in 11 of copyright. frequent in adults it is relatively rare in children, 12 children. No relapses were observed. so that large-scale studies are not possible. More- Electrocardiographic changes, consisting only of over, standardization of clinical criteria and manage- T wave inversion, were noted in 6 who received ment is more difficult than in adults. Age alone is emetine and in 3 given dehydroemetine. a most important factor in prognosis and can readily Although the immediate case fatality rate may not affect evaluation of treatment. In this study all be significantly influenced, a combination of either 4 deaths occurred among the 13 infants aged 16 preparation with chloroquine appears to reduce the months or less, whereas none of the remaining 11 relapse rate. Dehydroemetine is preferred to http://adc.bmj.com/ older children died. Regardless of the nature of emetine hydrochloride since not only may it be the therapy, mortality is higher in infants. more effective but it is possibly safer even in higher Some infants are only brought to hospital when dosage. the disease is so far advanced that it is difficult to imagine any form of therapy affecting cure. The We wish to thank Professor H. L. Wallace for advice necropsy appearances in the two infants who died and access to patients, and Dr. H. Wannenburg, Medical on the 2nd and 5th days of treatment suggested Superintendent, King Edward VIII Hospital, Durban, on September 28, 2021 by guest. Protected that the prognosis was hopeless from the outset. A for facilities. liver abscess of medium size in an adult is relatively enormous in an infant and causes extensive liver REFERENCES destruction. Consequently, the mortality of liver Powell, S. J. (1967). The cardiotoxicity of systemic amebicides: a abscess is to comparative electrocardiographic study. Amer. J. trop. Med. likely remain higher in infants despite Hyg., 16, 447. effective amoebicides. -, Wilmot, A. J., MacLeod, I. N., and Elsdon-Dew, R. (1965). The place of surgical drainage in management A comparative trial of dehydroemetine, emetine hydrochloride and chloroquine in the treatment of amoebic liver abscess. is not well defined. In our present study we Ann. trop. Med. Parasit., 59, 496. tended to resort to it at an earlier stage than previous- and - (1967). A comparative trial of dehydro- emetine and emetine hydrochloride in identical dosage in ly. Although it was only considered necessary in amoebic liver abscess. ibid., 61, 26. 6 patients, one of whom suddenly died, earlier Schwartz, D. E., and Herrero, J. (1965). Comparative pharmaco- surgery may have a in kinetic studies of dehydroemetine and emetine in guinea pigs been factor reducing both using spectrofluorometric and radiometric methods. Amer. the death and relapse rates. Premature surgical trop. Mod. Hyg., 14, 78. Arch Dis Child: first published as 10.1136/adc.43.227.121 on 1 February 1968. Downloaded from Emetine Hydrochloride and Dehydroemetine with Chloroquine in Amoebic Liver Abscess 123 Scragg, J. (1960). Amoebic liver abscess in African children. compared with chloroquine and emetine combined in amebic Arch. Dis. Childh., 35, 171. liver abscess. Amer. J. trop. Med. Hyg., 8, 623. -, and Powell, S. J. (1966). Emetine hydrochloride and chloro- quine in the treatment of children with amoebic liver abscess. -, -, MacLeod, I. N., and Elsdon-Dew, R. (1964). The ibid., 41, 549. treatment of amoebic liver abscess with dehydroemetine. Proc. Wilmot, A. J., Powell, S. J., and Adams, E. B. (1959). Chloroquine 3rd int. Congr. Chemother., Stuttgart, 1963, 2, 1528. copyright. http://adc.bmj.com/ on September 28, 2021 by guest. Protected 9.
Recommended publications
  • Index Vol. 12-15
    353 INDEX VOL. 12-15 Die Stichworte des Sachregisters sind in der jeweiligen Sprache der einzelnen Beitrage aufgefiihrt. Les termes repris dans la Table des matieres sont donnes selon la langue dans laquelle l'ouvrage est ecrit. The references of the Subject Index are given in the language of the respective contribution. 14 AAG (Alpha-acid glycoprotein) 120 14 Adenosine 108 12 Abortion 151 12 Adenosine-phosphate 311 13 Abscisin 12, 46, 66 13 Adenosine-5'-phosphosulfate 148 14 Absorbierbarkeit 317 13 Adenosine triphosphate 358 14 Absorption 309, 350 15 S-Adenosylmethionine 261 13 Absorption of drugs 139 13 Adipaenin (Spasmolytin) 318 14 - 15 12 Adrenal atrophy 96 14 Absorptionsgeschwindigkeit 300, 306 14 - 163, 164 14 Absorptionsquote 324 13 Adrenal gland 362 14 ACAI (Anticorticocatabolic activity in­ 12 Adrenalin(e) 319 dex) 145 14 - 209, 210 12 Acalo 197 15 - 161 13 Aceclidine (3-Acetoxyquinuclidine) 307, 13 {i-Adrenergic blockers 119 308, 310, 311, 330, 332 13 Adrenergic-blocking activity 56 13 Acedapsone 193,195,197 14 O(-Adrenergic blocking drugs 36, 37, 43 13 Aceperone (Acetabutone) 121 14 {i-Adrenergic blocking drugs 38 12 Acepromazin (Plegizil) 200 14 Adrenergic drugs 90 15 Acetanilid 156 12 Adrenocorticosteroids 14, 30 15 Acetazolamide 219 12 Adrenocorticotropic hormone (ACTH) 13 Acetoacetyl-coenzyme A 258 16,30,155 12 Acetohexamide 16 14 - 149,153,163,165,167,171 15 1-Acetoxy-8-aminooctahydroindolizin 15 Adrenocorticotropin (ACTH) 216 (Slaframin) 168 14 Adrenosterone 153 13 4-Acetoxy-1-azabicyclo(3, 2, 2)-nonane 12 Adreson 252
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Cutaneous Amebiasis in Pediatrics
    OBSERVATION Cutaneous Amebiasis in Pediatrics Mario L. Magan˜a, MD; Jorge Ferna´ndez-Dı´ez, MD; Mario Magan˜a,MD Background: Cutaneous amebiasis (CA), which is still Conclusions: Cutaneous amebiasis always presents with a health problem in developing countries, is important painful ulcers. The ulcers are laden with amebae, which to diagnose based on its clinical and histopathologic are relatively easy to see microscopically with routine features. stains. Erythrophagocytosis is an unequivocal sign of CA. Amebae reach the skin via 2 mechanisms: direct and in- Observations: Retrospective medical record review of direct. Amebae are able to reach the skin if there is a lac- 26 patients with CA (22 adults and 4 children) treated from eration (port of entry) and if conditions in the patient 1955 to 2005 was performed. In addition to the age and are favorable. Amebae are able to destroy tissues by means sex of the patients, the case presentation, associated ill- of their physical activity, phagocytosis, enzymes, secre- ness or factors, and method of establishing the diagnosis, tagogues, and other molecules. clinical pictures and microscopic slides were also analyzed. Arch Dermatol. 2008;144(10):1369-1372 UTANEOUS AMEBIASIS (CA) ria, are opportunistic organisms that act as can be defined as damage pathogens, usually in the immunocompro- to the skin and underly- mised host, who can develop disease in any ing soft tissues by tropho- organ, such as the skin and central ner- zoites of Entamoeba histo- vous system. This kind of amebiasis has be- lytica, the only pathogenic form for humans. come more common during the last few C 8-18 Cutaneous amebiasis may be the only ex- years.
    [Show full text]
  • International Journal for Scientific Research & Development| Vol. 4, Issue 09, 2016 | ISSN (Online): 2321-0613
    IJSRD - International Journal for Scientific Research & Development| Vol. 4, Issue 09, 2016 | ISSN (online): 2321-0613 Study of Percentage Tinidazole in Different Brands of Antiprotozoal Tablets Contation Tinidazole Shiv Pratap Singh Dangi1 R.N. Shukla2 P.K. Sharma3 1Msc Student 2Professor & HOD 3Associated Professor 1,2,3Department of Applied Chemistry 1,2,3Samrat Ashok Technological Institute Vidisha (M.P.) 464001 [India] Abstract— Protozoal diseases particularly malaria, leishmaniasis and changes disease, are major cause of II. MATERIALS AND METHODS mortality in various tropical and subtropical regions. Where Antiprotozoal are drugs to treat infection cause by A. Collection of Samples: unicellular organisms that destroy protozoa or inhibit their I have collected four samples of different brands of growth and the ability to reproduce. Protozoal infection antiprotozoal tablets containing Tinidazole then desigenteted transmission can be person to person by infected water or as, TZ-1, TZ-2, TZ-3 and TZ-4. food, direct contact with a parasite, a mosquito or tick. B. Chemical and Reagents: Tinidazole is the most preferred choice of drug for intestinal amoebiasis. The aim of this study is to carry out the quality Methanol, Acetone, Dichloromethane and distilled water, all test of different brands of Tinidazole Tablets I analyzed solvents and reagents used were of analytical grade. various parameters such as identification, solubility and % assay to check the quality. All the tablets compared with III. METHODS authorized standard were found within the range. A. Description Key words: Tinidazole, Anti-protozoal, Amoebiasis, The description of each sample was performed as per the IP Protozoal disease, Anti-protozoal drug volume (III) 2007[10].
    [Show full text]
  • CRUX 71Sepoct2015
    VOLUME - XII ISSUE - LXXI SEP/OCT 2015 Amoebiasis, also known as amebiasis or entamobiasis, is an infection caused by any of the amoebas of the Entamoeba group. Symptoms are most common upon infection by Entamoeba histolytica. Amoebiasis can present with no, mild, or severe symptoms. Symptoms may include abdominal pain, mild diarrhoea, bloody diarrhea or severe colitis with tissue death and perforation. This last complication may cause peritonitis. People affected may develop anemia due to loss of 1 Editorial blood. Disease Invasion of the intestinal lining causes amoebic bloody diarrhea or amoebic colitis. If the parasite 2 reaches the bloodstream it can spread through the body, most frequently ending up in the liver Diagnosis where it causes amoebic liver abscesses. Liver abscesses can occur without previous diarrhea. Cysts of entamoeba can survive for up to a month in soil or for up to 45 minutes under fingernails. It 9 Trouble is important to differentiate between amoebiasis and bacterial colitis. The preferred diagnostic Shooting method it through faecal examination under microscope, but requires a skilled microscopist and may not be reliable when excluding infection. Increased white blood cell count is present in severe 10 Bouquet cases, but not in mild ones. The most accurate test is for antibodies in the blood, but it may remain positive following treatment. Prevention of amoebiasis is by separating food and water from faeces and by proper sanitation 11 Interpretation measures. There is no vaccine. There are two treatment options depending on the location of the infection. Amoebiasis in tissues is treated with either metronidazole, tinidazole, nitazoxanide, 12 Tulip News dehydroemetine or chloroquine, while luminal infection is treated with diloxanide furoate or iodoquinoline.
    [Show full text]
  • POISONS LIST APPENDIX Amoebicides: Carbarsone
    POISONS LIST APPENDIX Amoebicides: Carbarsone Clioquinol and other halogenated hydroxyquinoline compounds Dehydroemetine; its salts Diloxanide; its compounds Dimetridazole Emetine Ipronidazole Metronidazole Pentamidine; its salts Ronidazole Anaesthetics: Alphadolone acetate Alphaxolone Desflurane Disoprofol Enflurane Ethyl ether Etomidate; its salts Halothane Isoflurane Ketamine; its salts Local anaesthetics, the following: their salts; their homologues and analogues; their molecular compounds Amino-alcohols esterified with benzoic acid, phenylacetic acid, phenylpropionic acid, cinnamic acid or the derivatives of these acids; their salts Benzocaine Bupivacaine Butyl aminobenzoate Cinchocaine Diperodon Etidocaine Levobupivacaine Lignocaine Mepivacaine Orthocaine Oxethazaine Phenacaine Phenodianisyl Prilocaine Ropivacaine Phencyclidine; its salts Propanidid Sevoflurane Tiletamine; its salts Tribromoethanol Analeptics and Central Stimulants: Amiphenazole; its salts Amphetamine (DD) Bemegride Cathine Cathinone (DD) Dimethoxybromoamphetamine (DOB) (DD) 2, 5-Dimethoxyamphetamine (DMA) (DD) 2, 5-Dimethoxy-4-ethylamphetamine (DOET) (DD) Ethamivan N-Ethylamphetamine; its salts N-Ethyl MDA (DD) N-Hydroxy MDA (DD) Etryptamine (DD) Fencamfamine Fenetylline Lefetamine or SPA or (-)-1-dimethylamino-1, 2-diphenylethane Leptazol Lobelia, alkaloids of Meclofenoxate; its salts Methamphetamine (DD) Methcathinone (DD) 5-Methoxy-3, 4-methylenedioxyamphetamine (MMDA) (DD) Methylenedioxyamphetamine (MDA) (DD) 3, 4-Methylenedioxymetamphetamine (MDMA) (DD) Methylphenidate;
    [Show full text]
  • Short Reports Metronidazole in Treatment of Children with Amoebic Liver Abscess
    Arch Dis Child: first published as 10.1136/adc.48.11.911 on 1 November 1973. Downloaded from Short reports Archives of Disease in Childhood, 1973, 48, 911. Metronidazole in treatment of multiple abscesses which were not accessible by needle aspiration. All recovered but were given children with amoebic liver dehydroemetine during the postoperative period. abscess No relapses were observed during a 3-month follow-up. We have shown that metronidazole combined with dehydroemetine is an effective treatment of Discussion children with amoebic liver abscess and that the The results of this trial are similar to those former drug has advantages over chloroquine obtained in our previous study of metronidazole (Scragg and Powell, 1970). In adults, metro- combined with dehydroemetine in which 11 of 15 nidazole in the absence of other drug therapy is children were cured, 2 more required surgical extremely effective in curing amoebic liver abscess drainage, and 2 died (Scragg and Powell, 1970). and remains the best of the nitroimidazole We have indicated that age is a most important derivatives that we have investigated (Powell, 1972; factor in prognosis and that, regardless of the nature Powell and Elsdon-Dew, 1972). However, in the ofthe therapy, mortality is higher in infants and very very young we have been reluctant to abandon young children (Scragg and Powell, 1968). In the parenteral emetine preparations owing to the present study the average age of our patients was severity of the condition in this age group. Never- significantly lower than in our previous trials, hence theless, the highly satisfactory results that we have the efficacy of metronidazole alone was put to a obtained with metronidazole alone in hundreds of rigorous test.
    [Show full text]
  • Appendix I. Therapeutic Recommendations (Reprinted from the Medical Letter) the Medical Letter® on Drugs and Therapeutics
    Appendix I. Therapeutic Recommendations (Reprinted from The Medical Letter) The Medical Letter® On Drugs and Therapeutics Published by The Medical Letter, Inc .• 1000 Main Street, New Rochelle, NY. 10801 • A Nonprofit Publication Vol. 35 (Issue 911) December 10, 1993 DRUGS FOR PARASITIC INFECTIONS Parasitic infections are found throughout the world. With increasing travel, immigration, use of immunosuppressive drugs, and the spread of AIDS, physicians anywhere may see infections caused by previously unfamiliar parasites. The table below lists first-choice and alternative drugs for most parasitic infections. Adverse effects of antiparasitic drugs are listed on page 120. For information on the safety of antiparasitic drugs in pregnancy, see The Medical Letter Handbook of Antimicrobial Therapy, 1992, page 151. DRUGS FOR TREATMENT OF PARASITIC INFECTIONS Infection Drug Adult Dosage* Pediatric Dosage* AMEBIASIS (Entamoeba histolytica) a.ymptomatlc Drug of choice: lodoquinol' 650 mg tid x 20d 30-40 mg/kg/d in 3 doses x 20d OR Paromomycin 25-30 mg/kg/d in 3 doses x 7d 25-30 mg/kg/d in 3 doses x 7d Alternative: Diloxanide furoate' 500 mg tid x 10d 20 mg/kg/d in 3 doses x 10d mild to mod.rat. Int•• tlnal dl••••• Drugs of choice:3 Metronidazole 750 mg tid x 10d 35-50 mg/kg/d in 3 doses x 10d OR Tinidazole' 2 grams/d x 3d 50 mg/kg (max. 2 grams) qd x 3d s.v.r. Int•• tlnal dis.as. Drugs of choice:3 Metronidazole 750 mg tid x 10d 35-50 mg/kg/d in 3 doses x 10d OR Tinidazole' 600 mg bid x 5d 50 mg/kg (max.
    [Show full text]
  • Hepatic Amebiasis: Experience in the Therapy of 56 Cases*
    .4(1.4 AIH) l’ORJ.S,,pp/ 2. 303. 19111 HEPATIC AMEBIASIS: EXPERIENCE IN THE THERAPY OF 56 CASES* Ireneu Cruz and F. J. Z. Carneiro Chaves Serviço 2. Medicina. Hospital de Curry Cabral. Lisboa.Serviço de Terapêutica Médica (Medicina 11). Faculdade de Medicina. Hospital de S. João. Porto. SUMMARY The resulta of therapy in 56 consecutive cases of hepatic amebiasis are reviewed. In retrospecr, the resulta in patients receiving metronidazole alone, dehydroemetine combined with chioroquine, and dehydroemetine combined with chloroquine and metronidazole were compared. No deaths occured. Our resulta confirm the great efficacy of metronidazole alone. The response to treatment was similar in patients receiving dehydroemetine combined with chloroquine but the average number of days of hospitalization was greater in these patients. No advantage was demonstrated for rhe combination of metronidazole with dehydroe metine and chioroquine. In retrospect these patients proved to have a more severe and protracted course with more frequent surgical complications and a greater need for closed aspiration of the abscess. Closed aspiration, not used routinely, has not reduced the number of days of hospitaliza tion. Significant side effects were not observed. Arnebicidai drug therapy has dramatically changed the prognosis of hepatic ame biasis, nowadays a readily curable disease (Poweli, 1971). Enduring landmarks in the development of drug therapy were the introduction of emetine hydrochloride (Rodgers, 1912), foliowed by chloroquine (Conan, 1948) and later by metronidazole (Powell et ai, 1966). The efficacy of these drugs, in single or combined drug regimens has been weli proved (Powell, 1971; Adams and MacLeod, 1977). The purpose of the present study is to review in retrospect our experience with three drug regimens in 56 consecutive cases of hepatic amebiasis.
    [Show full text]
  • AMEBIASIS [Amebic Dysentery, Amebiosis]
    AMEBIASIS [Amebic Dysentery, Amebiosis] SPECIES: Nonhuman primates primary laboratory risk AGENT: Entamoeba histolytica. RESERVOIR AND INCIDENCE: The reservoir of E. histolytica is man. The infections is present worldwide but is most prevalent and severe in tropical areas, where rates may exceed 40% under conditions of crowding, poor sanitation, and poor nutrition. It is estimated that there are about 50 million case of invasive amebiasis and 40,000- 100,000 deaths annually worldwide. In temperate areas, however, amebiasis tends to be asymptomatic or a mild, chronic infection that often remains undiagnosed. In the USA, seropositive rates up to 2-5% have been reported in some populations. Reported incidence of 0-31% in the feces of clinically normal Rhesus monkeys, 2-67% in Chimps, and up to 30% in other NHP. TRANSMISSION: Transmission may be by ingestion of infective cysts, contaminated water or food, by flies, or fomites. Resistant cysts or more fragile trophozoites CYSTS are the INFECTIOUS form found in the stool of asymptomatic carriers or patients with mild disease. The cysts remain viable, if moist and cool for 12 days. They remain viable for 30 days in water. Laboratory animal personnel are usually infected from fecal matter transferred to the skin or clothing. DISEASE IN ANIMALS: In dogs, infection by E. histolytica is generally asymptomatic and frequently localized in the cecum. Occasionally, it can invade tissues and cause acute or chronic amebiasis. Rhesus monkeys are generally resistant and usually experience asymptomatic infection, but chronic, mild colitis can occur. In chimpanzees, the infection can persist for a long time, in most cases subclinically, but sometimes it invades the tissues causing ulcerative colitis and hepatic abscesses.
    [Show full text]
  • Cutaneous Amebiasis: 50 Years of Experience
    Cutaneous Amebiasis: 50 Years of Experience Jorge Fernández-Díez, MD; Mario Magaña, MD; Mario L. Magaña, MD Although cutaneous amebiasis (CA) is a rare of skin and subcutaneous tissues. Therefore, CA disease, it is a public health concern worldwide, is a particularly virulent form of amebiasis. particularly in developing nations. It gains impor- Cutis. 2012;90:310-314. tance because of its severe clinical course, which can be confused with other disorders. Therefore, knowledge of its clinical features, histopathology, utaneous amebiasis (CA) can be charac- and pathogenesis is essential. We present a retro- terized as injury to the skin and underly- spective analysis over 50 years of 26 patients with ing soft tissues by trophozoites of Entamoeba C 1,2 CA who were diagnosed and treated at 2 Mexican histolytica. Other species of the genus such as institutions. Our main focus was to draw clinical Entamoeba hartmanni, Entamoeba coli, Entamoeba information to identify mechanisms by which ame- gingivalis,3 and Entamoeba dispar4 are considered bae reach the skin, occurring in a relatively small nonpathogenic. Entamoeba dispar has now been rec- percentage of infected individuals. The recorded ognized as responsible for many cases of amebiasis data included age and sex ofCUTIS the patients, form of in patients who were previously considered “healthy presentation, any associated illnesses and/or fac- carriers.” It is morphologically indistinguishable from tors, and methods for diagnosis. Histologic slides E histolytica but genetically and serologically dif- were reviewed in all cases; cytologic preparations ferent.5,6 Entamoeba moshkovskii is morphologically also were available for 6 cases. Most patients indistinguishable from E histolytica and E dispar but were male (overall male to female ratio, 1.9 to 1).
    [Show full text]